217 related articles for article (PubMed ID: 1698306)
21. Langerhans cells but not monocytes are capable of antigen presentation in vitro in corticosteroid contact hypersensitivity.
Lauerma AI; Räsänen L; Reunala T; Reitamo S
Br J Dermatol; 1990 Dec; 123(6):699-705. PubMed ID: 2265088
[TBL] [Abstract][Full Text] [Related]
22. Expression of OKM5 antigen on epidermal cells in mycosis fungoides plaque stage.
Lisby S; Baadsgaard O; Cooper KD; Thomsen K; Wantzin GR
J Invest Dermatol; 1988 May; 90(5):716-9. PubMed ID: 2452212
[TBL] [Abstract][Full Text] [Related]
23. Novel predictive assay for contact allergens using human skin explant cultures.
Pistoor FH; Rambukkana A; Kroezen M; Lepoittevin JP; Bos JD; Kapsenberg ML; Das PK
Am J Pathol; 1996 Jul; 149(1):337-43. PubMed ID: 8686758
[TBL] [Abstract][Full Text] [Related]
24. Antigen-presenting cells in the induction of contact hypersensitivity in mice: evidence that Langerhans cells are sufficient but not required.
Sreilein JW
J Invest Dermatol; 1989 Oct; 93(4):443-8. PubMed ID: 2778349
[TBL] [Abstract][Full Text] [Related]
25. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
[TBL] [Abstract][Full Text] [Related]
26. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
Sontheimer RD
J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
[TBL] [Abstract][Full Text] [Related]
27. [Langerhans' cell].
Thivolet J
Presse Med; 1985 Apr; 14(16):883-8. PubMed ID: 3158923
[TBL] [Abstract][Full Text] [Related]
28. CD1-positive epidermal Langerhans cells in regressed tuberculoid and lepromatous leprosy lesions.
Narayanan RB; Girdhar A; Girdhar BK
Int Arch Allergy Appl Immunol; 1990; 92(1):94-6. PubMed ID: 1700968
[TBL] [Abstract][Full Text] [Related]
29. Quantitative immunohistochemical differences in Langerhans cells in dermatitis due to internal versus external antigen sources.
Prieto VG; Sadick NS; McNutt NS
J Cutan Pathol; 1998 Jul; 25(6):301-10. PubMed ID: 9694619
[TBL] [Abstract][Full Text] [Related]
30. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
[TBL] [Abstract][Full Text] [Related]
31. Studies on human epidermal Langerhans cells III. Induction of T lymphocyte response to nickel sulphate in sensitized individuals.
Braathen LR
Br J Dermatol; 1980 Nov; 103(5):517-26. PubMed ID: 6969088
[TBL] [Abstract][Full Text] [Related]
32. In vivo ultraviolet-exposed human epidermal cells activate T suppressor cell pathways that involve CD4+CD45RA+ suppressor-inducer T cells.
Baadsgaard O; Salvo B; Mannie A; Dass B; Fox DA; Cooper KD
J Immunol; 1990 Nov; 145(9):2854-61. PubMed ID: 1976706
[TBL] [Abstract][Full Text] [Related]
33. Distribution of MHC-II and CD1 molecules in the skin of lambs and changes during experimentally-induced contact hypersensitivity.
Jörundsson E; Press CM; Landsverk T
Vet Immunol Immunopathol; 2000 Apr; 74(1-2):87-101. PubMed ID: 10760392
[TBL] [Abstract][Full Text] [Related]
34. T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.
Demidem A; Taylor JR; Grammer SF; Streilein JW
J Invest Dermatol; 1991 Sep; 97(3):454-60. PubMed ID: 1875046
[TBL] [Abstract][Full Text] [Related]
35. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
36. Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.
Kurimoto I; Grammer SF; Shimizu T; Nakamura T; Streilein JW
Immunology; 1995 Aug; 85(4):621-9. PubMed ID: 7558158
[TBL] [Abstract][Full Text] [Related]
37. Effects of topical corticosteroid therapy on Langerhans cell antigen presenting function in human skin.
Ashworth J; Booker J; Breathnach SM
Br J Dermatol; 1988 Apr; 118(4):457-69. PubMed ID: 3288268
[TBL] [Abstract][Full Text] [Related]
38. Antigen presentation and T-cell activation in epidermodysplasia verruciformis.
Cooper KD; Androphy EJ; Lowy D; Katz SI
J Invest Dermatol; 1990 Jun; 94(6):769-76. PubMed ID: 2162366
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical comparison of actinic reticuloid with allergic contact dermatitis.
Fujita M; Miyachi Y; Horio T; Imamura S
J Dermatol Sci; 1990 Jul; 1(4):289-96. PubMed ID: 1710141
[TBL] [Abstract][Full Text] [Related]
40. Dynamic changes in epidermal Ia-positive cells in allergic contact sensitivity reactions in mice.
Aiba S; Aizawa H; Obata M; Tagami H
Br J Dermatol; 1984 Nov; 111(5):507-16. PubMed ID: 6388619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
